{"result": "(\"entity\"<|>CASTILLA Y LEÓN<|>GEO<|>Castilla y León is an autonomous community in Spain where clinical case conferences related to diabetes and nutrition were held.)\n##\n(\"entity\"<|>NUTRICIÓN<|>EVENT<|>Nutrition is a key focus in the management of diabetes, particularly in clinical cases discussed in the context of diabetes mellitus.)\n##\n(\"entity\"<|>TRASTORNO DEL COMPORTAMIENTO ALIMENTARIO<|>EVENT<|>Eating disorders are a significant concern for patients with diabetes, particularly in the context of clinical cases presented by Dra. Ana Isabel Sánchez Marcos.)\n##\n(\"relationship\"<|>DRA. ANA ISABEL SÁNCHEZ MARCOS<|>TRASTORNO DEL COMPORTAMIENTO ALIMENTARIO<|>Dra. Ana Isabel Sánchez Marcos specializes in the treatment of eating disorders in diabetic patients<|>8)\n##\n(\"relationship\"<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>NUTRICIÓN<|>The Hospital Clínico Universitario de Valladolid conducts research and clinical cases focused on nutrition in diabetes management<|>7)\n##\n(\"relationship\"<|>DIABETES MELLITUS TIPO 2<|>NUTRICIÓN<|>Nutrition plays a critical role in managing Diabetes Mellitus Type 2, as discussed in clinical cases<|>6)\n##\n(\"relationship\"<|>CASTILLA Y LEÓN<|>PERSAN FARMA<|>PERSAN FARMA sponsored clinical case conferences in Castilla y León<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: .\nDirector científico.\nJefe del Servicio de Endocrinología y Nutrición.\nHospital Clínico Universitario de Valladolid.\n\n\n\ncasos clínicos:\nTrastorno del comportamiento alimentario en paciente DM1.\nDra. Ana Isabel Sánchez Marcos ................................................................. 81\nManejo nutricional del paciente diabético con pancreatitis aguda… Ningún\ndía es igual a otro.\nDra. Estefanía Santos Mazo ........................................................................ 92\n\n\n\n                                                                                                        79\n---\n    Casos clínicos de nutrición\n    y diabetes                  mellitus tipo 2\n    Prof. Dr. Daniel de Luis Román\n    Catedrático de Endocrinología y Nutrición. Universidad de Valladolid.\n    Jefe de Servicio de Endocrinología y Nutrición.\n    Hospital Clínico Universitario de Valladolid.\n    Director del Área de Ciencias de la Salud adscrito al Rector Uva.\n    Director del Centro de Investigación de Endocrinologia y Nutrición.\n    Facultad de Medicina. Valladolid.\n    www.ienva.org\n    Presidente de la Scledyn.\n\n\n\n             En la actualidad la diabetes           mellitus tipo 2 (DM2) es un problema de primer\n    orden, por ejemplo, en España se estima una prevalencia en población general del\n    13,8%, con un 6% de los pacientes que no conocen que padecen esta enfermedad. Por\n    otra parte la desnutrición relacionada con la enfermedad (DRE) aparece en un 23% de\n    los pacientes ingresados, produciendo un claro aumento de la morbimortalidad de los\n    pacientes.\n\n\n\n             En esta serie de libros/foros se incluyen una serie de casos clínicos que repasan\n    diferentes patologías que producen situaciones de desnutrición o riesgo nutricional\n    en pacientes con DM2. Las publicaciones nacen de la experiencia de unas jornadas de\n    casos clínicos patrocinados por laboratorios PERSAN FARMA en varias localizaciones de\n    nuestro país que han permitido poner en común diferentes aspectos de la valoración\n    nutricional, soporte nutricional avanzado y uso de fórmulas específicas para el paciente\n    con DM2. En las jornadas realizadas en Castilla y León se revisaron casos relacionados\n    con la diabetesmellitus tipo 1, trastornos del comportamiento alimentario y pancreati-\n    tis aguda.\n\n\n\n             En un mundo interconectado con una generación de conocimiento que no nos\n    permite “digerir” toda la información relevante que aparece, estas obra tratan de\n    sintetizar de manera clara y práctica a modo de casos clínicos resueltos, el abordaje de\n    diferentes patologías de elevada complejidad, en las que las Guías de Práctica Clínica a\n    veces no se han posicionado de manera clara o existen dudas razonables en el abordaje\n    diagnóstico y terapéutico nutricional. Deseamos que este manual os sea útil para el\n    abordaje diario de vuestros pacientes.\n\n\n\n80\n---\n  Caso Clínico\nTrastorno del comportamiento\nalimentario en paciente DM1\nDra. Ana Isabel Sánchez Marcos\nMédico Especialista en Endocrinología y Nutrición.\nUnidad de Trastornos del Comportamiento Alimentario del Complejo Asistencial Universitario\nde Salamanca (UTCA-CAUSA).\n\n\n\nResumen\n         Los pacientes con diabetes tipo 1 (DM1), especialmente las mujeres jóvenes, tie-\nnen un riesgo 2,4 veces mayor de padecer trastornos del comportamiento alimentario\n(TCA) que sus pares no diabéticas. Tanto algunos síntomas de la DM1 como aspectos\nsu tratamiento son factores de riesgo para desarrollar TCA. El caso que presentamos es\nuna mujer de 14 años en el momento de la primera consulta, con DM1 desde los 8 años\nen la que la aparición del TCA supone un punto de inflexión tanto en el control de su en-\nfermedad diabética como en la estabilidad de su situación nutricional. Estas pacientes\nsuponen un reto para el clínico que debe sospechar precozmente el problema, aunque\nlas herramientas de screening habituales no recogen las características especiales de\nestos casos y abordar el tratamiento conjuntamente con Salud Mental, de forma coor-\ndinada y consensuada, postergando el tratamiento intensivo de la hiperglucemia hasta\nque la clínica de TCA esté estabilizada. Existen ya trabajos que prueban que la terapia\ncon infusión subcutánea continua de insulina (ISCI) no solo es segura en este tipo de\ncasos, sino    que mejora el control metabólico de las pacientes con TCA.\n\n\n\n         Debido a la persistencia de las conductas de TCA en la vida adulta, especialmen-\nte la omisión de insulina como forma de perder peso (en algunas series casi 40% de las\nmujeres) y el riesgo aumentado de mortalidad y desarrollo de\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>ORGANIZATION<|>The Hospital Clínico Universitario de Valladolid is a medical institution specializing in endocrinology and nutrition, involved in clinical cases related to diabetes and nutritional disorders.)\n##\n(\"entity\"<|>DRA. ANA ISABEL SÁNCHEZ MARCOS<|>PERSON<|>Dra. Ana Isabel Sánchez Marcos is a specialist in endocrinology and nutrition, working at the Hospital Clínico Universitario de Valladolid, focusing on eating disorders in diabetic patients.)\n##\n(\"entity\"<|>DRA. ESTEFANÍA SANTOS MAZO<|>PERSON<|>Dra. Estefanía Santos Mazo is a medical professional involved in the nutritional management of diabetic patients, contributing to clinical cases at the Hospital Clínico Universitario de Valladolid.)\n##\n(\"entity\"<|>PROF. DR. DANIEL DE LUIS ROMÁN<|>PERSON<|>Prof. Dr. Daniel de Luis Román is a professor of endocrinology and nutrition at the University of Valladolid, and he is the head of the endocrinology and nutrition service at the Hospital Clínico Universitario de Valladolid.)\n##\n(\"entity\"<|>UNIVERSIDAD DE VALLADOLID<|>ORGANIZATION<|>The University of Valladolid is an educational institution where Prof. Dr. Daniel de Luis Román teaches and conducts research in endocrinology and nutrition.)\n##\n(\"entity\"<|>PERSAN FARMA<|>ORGANIZATION<|>PERSAN FARMA is a pharmaceutical company that sponsored clinical case conferences related to nutrition and diabetes in Spain.)\n##\n(\"entity\"<|>COMPLEJO ASISTENCIAL UNIVERSITARIO DE SALAMANCA<|>ORGANIZATION<|>The Complejo Asistencial Universitario de Salamanca is a healthcare facility where Dra. Ana Isabel Sánchez Marcos works in the Eating Disorders Unit.)\n##\n(\"entity\"<|>DIABETES MELLITUS TIPO 1<|>EVENT<|>Diabetes Mellitus Type 1 is a chronic condition that requires careful management, particularly in young women who are at higher risk for eating disorders.)\n##\n(\"entity\"<|>DIABETES MELLITUS TIPO 2<|>EVENT<|>Diabetes Mellitus Type 2 is a prevalent health issue in Spain, affecting a significant portion of the population and leading to various nutritional challenges.)\n##\n(\"relationship\"<|>DRA. ANA ISABEL SÁNCHEZ MARCOS<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>Dra. Ana Isabel Sánchez Marcos works as a specialist in endocrinology and nutrition at the Hospital Clínico Universitario de Valladolid<|>9)\n##\n(\"relationship\"<|>DRA. ESTEFANÍA SANTOS MAZO<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>Dra. Estefanía Santos Mazo is involved in clinical cases at the Hospital Clínico Universitario de Valladolid<|>8)\n##\n(\"relationship\"<|>PROF. DR. DANIEL DE LUIS ROMÁN<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>Prof. Dr. Daniel de Luis Román is the head of the endocrinology and nutrition service at the Hospital Clínico Universitario de Valladolid<|>9)\n##\n(\"relationship\"<|>PROF. DR. DANIEL DE LUIS ROMÁN<|>UNIVERSIDAD DE VALLADOLID<|>Prof. Dr. Daniel de Luis Román teaches at the University of Valladolid<|>8)\n##\n(\"relationship\"<|>DRA. ANA ISABEL SÁNCHEZ MARCOS<|>COMPLEJO ASISTENCIAL UNIVERSITARIO DE SALAMANCA<|>Dra. Ana Isabel Sánchez Marcos works in the Eating Disorders Unit at the Complejo Asistencial Universitario de Salamanca<|>9)\n##\n(\"relationship\"<|>PERSAN FARMA<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>PERSAN FARMA sponsored clinical case conferences at the Hospital Clínico Universitario de Valladolid<|>6)\n##\n(\"relationship\"<|>DIABETES MELLITUS TIPO 1<|>DRA. ANA ISABEL SÁNCHEZ MARCOS<|>Dra. Ana Isabel Sánchez Marcos specializes in managing patients with Diabetes Mellitus Type 1<|>7)\n##\n(\"relationship\"<|>DIABETES MELLITUS TIPO 2<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>The Hospital Clínico Universitario de Valladolid addresses clinical cases related to Diabetes Mellitus Type 2<|>6)\n<|COMPLETE|>"}]}